pDONR223-CAMK2G Citations (2)
Originally described in: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.Johannessen CM, Boehm JS, Kim SY, Thomas SR, Wardwell L, Johnson LA, Emery CM, Stransky N, Cogdill AP, Barretina J, Caponigro G, Hieronymus H, Murray RR, Salehi-Ashtiani K, Hill DE, Vidal M, Zhao JJ, Yang X, Alkan O, Kim S, Harris JL, Wilson CJ, Myer VE, Finan PM, Root DE, Roberts TM, Golub T, Flaherty KT, Dummer R, Weber BL, Sellers WR, Schlegel R, Wargo JA, Hahn WC, Garraway LA Nature. 2010 Nov 24. ():. PubMed Journal
Articles Citing pDONR223-CAMK2G
| Articles |
|---|
| Suppression of CaMKIIbeta Inhibits ANO1-Mediated Glioblastoma Progression. Sim KM, Lee YS, Kim HJ, Cho CH, Yi GS, Park MJ, Hwang EM, Park JY. Cells. 2020 Apr 26;9(5). pii: cells9051079. doi: 10.3390/cells9051079. PubMed |
| p21-Activated Kinase 1 Promotes Breast Tumorigenesis via Phosphorylation and Activation of the Calcium/Calmodulin-Dependent Protein Kinase II. Saldivar-Ceron HI, Villamar-Cruz O, Wells CM, Oguz I, Spaggiari F, Chernoff J, Patino-Lopez G, Huerta-Yepez S, Montecillo-Aguado M, Rivera-Pazos CM, Loza-Mejia MA, Vivar-Sierra A, Briseno-Diaz P, Zentella-Dehesa A, Leon-Del-Rio A, Lopez-Saavedra A, Padierna-Mota L, Ibarra-Sanchez MJ, Esparza-Lopez J, Hernandez-Rivas R, Arias-Romero LE. Front Cell Dev Biol. 2022 Jan 17;9:759259. doi: 10.3389/fcell.2021.759259. eCollection 2021. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.